All
Sonidegib offers new option for basal cell cancer
December 9th 2015A newly approved medication called sonidegib (Odomzo) gives physicians a second option in a class of medications designed to treat a small number of patients who suffer from locally advanced basal cell carcinoma and meet other criteria. Learn more
Should you wait after isotretinoin to treat acne with laser?
December 4th 2015Dermatology Times editorial advisor, Dr. Elaine Siegfried continues the discussion on isotretinoin with Jim Leyden, M.D., emeritus professor of dermatology at the University of Pennsylvania. In this final segment, the two discuss whether a waiting period is necessary before treating acne scars and the questionable existence of pityrosporum folliculitis.
Which physician lifestyle issue is most important to you?
November 27th 2015In the midst of a changing healthcare climate, increased patient loads, new technologies, dermatologists are feeling the stress. Is there one particular pain point that is more important than another? You tell us and we’ll share the collected, anonymous responses in an upcoming post!
8 simple tips for happy patients
November 16th 2015Unhappy patients discourage dermatologists and staff, and they result in negative feedback and business loss. What turns anxious and grumpy into calm and happy? A few of Dermatology Times’ Editorial Advisory Board members share their favorite tricks.
Facial erythema influences perceptions
November 12th 2015A recent study shows people with facial erythema were strongly associated with having poor health and negative personality traits. Participants reported negative impacts of rosacea emotionally, socially, and at work. Doctors should seek to address both the aesthetic as well as the psychological impacts of the disease.
Keys to managing adverse drug reactions
November 11th 2015The drugs that physicians prescribe are generally believed to be safe, having typically undergone thorough FDA scrutiny. Nevertheless, adverse drug reactions do occur and knowing which drugs are common offenders and how to best identify potential offenders is crucial in optimally treating and managing patients with adverse drug reactions.